Biopharmaceutical classification system In invitro/ In-vivo correlation: Concept and development strategies in drug delivery

Tropical Journal of Pharmaceutical Research

Volumn 11, Issue 2, 2012, Pages 319-329

  Nainar, Sundaramoorthi ^a   Rajiah, Kingston ^b   Angamuthu, Santhosam ^a   Prabakaran, D ^a   Kasibhatta, Ravisekhar ^a  

^a LUPIN LIMITED   (India)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Biopharmaceutical Classification System; Drug Delivery; In vitro in vivo correlation

Indexed keywords

ALBENDAZOLE; AMINOPHYLLINE; ATOVAQUONE; BUSPIRONE; CARBAMAZEPINE; DANAZOL; DICLOFENAC; GLIMEPIRIDE; GRISEOFULVIN; KETOCONAZOLE; LEVOFLOXACIN; LEVOTHYROXINE; METFORMIN; METOPROLOL; NAPROXEN; NICOTINE; NICOTINIC ACID; NIFEDIPINE; NIMESULIDE; PARACETAMOL; PENICILLIN V POTASSIUM; PIROXICAM; PSEUDOEPHEDRINE; RETINOIC ACID; ROXATIDINE; SALBUTAMOL SULFATE; THEOPHYLLINE;

ABSORPTION; ACCURACY; CONTROLLED DRUG RELEASE; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; EVALUATION RESEARCH; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PREDICTION; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 84859972661     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v11i2.20     Document Type: Review

References (46)

1. Eva MD, Amo AT, Heikkinen JM. In vitro-in vivo correlation in p-glycoprotein mediated transport in intestinal absorption. Eur. J. Pharm. Sci. 2009; 36: 200-211
2. Jaber E. In vitro - In vivo Correlation: From Theory to Applications. J Pharm Pharmaceut Sci, 2006; 9: 169-189
3. Ulrich H, Florian S, Rolf D. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. Eur. J. Pharm. Biopharm. 2010; 76 (1): 105-111
4. Tom J, Stefaan R, Adrian DG. Combined Models for Data from In Vitro-In Vivo Correlation Experiments. J. Biopharm. Stat. 2008; 18: 1197-1211
5. Mohd Y, Mohd A, Ashwani K. Biopharmaceutical Classification System: An Account. International J Pharm Tech Research. 2010; 2: 1681-1690
6. Venkata R, Uppoor S. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. J. Control. Rel. 2001; 72: 127-132
7. Saeed AQ. In Vitro-In Vivo Correlation (IVIVC) and Determining Drug Concentrations in Blood from Dissolution Testing - A Simple and Practical Approach. Open Drug Deliv J, 2010; 4, 38-47
8. Cardot JM, Beyssac E, Alric M. In Vitro-In Vivo Correlation: Importance of Dissolution in IVIVC. Dissolution Technologies. 2007; 7: 15-19
9. Buchwald P. Direct differential-equation-based invitro-in-vivo correlation (IVIVC) method. J Pharm Pharmacol, 2003; 55 (4): 495-504
10. Ewout WS, Sacha EB, Henriëtte AM, Diederick EG, Karel GM. Internal and external validation of predictive models: A simulation study of bias and precision in small samples J Clin Epidemiol, 2003; 56(5): 441-447
11. Nattee S, Natalie DE. In-Vitro-In-Vivo Correlation Definitions and Regulatory Guidance. Int. J. of Generic Drugs. ISSN 0793 7776: 1-11
12. Esra D, Levent Ö. In Vitro - In Vivo Correlations. J. Pharm. Sci. 2003; 28: 215-224
13. Ghulam M, Mahmood A, Naveed A. Biowaiver study of oral tabletted ethylcellulose microcapsules of a BCS class I drug. Bull. Chem. Soc. Ethiop. 2009; 231: 175-186
14. Sevgi T, Adel S, Arthur G. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. J. Control. Rel. 2003; 88: 147-157
15. Nattee S, Natalie DE. Systematic Method for the Development and Validation of an IVIVC Metoprolol and Naproxen Drug Examples. Int. J. of Generic Drugs. IVIVC Series Part III, ISSN 0793 7784 Euro.
16. Turner S, Federici C, Hite M. Formulation Development and Human in Vitro-In Vivo Correlation for a Novel, Monolithic Controlled-Release Matrix System of High Load and Highly Water-Soluble Drug Niacin. Drug Dev. Ind. Pharm. 2004; 30: 797-807
17. Fotaki N, Aivaliotis A, Butler J. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations. Eur. J. Pharm. Biopharm. 2009; 73: 115-120
18. Fatima R, Mahmood A, Ghulam M. Metoprolol Tartrate-Ethylcellulose Tabletted Microparticles: Development of a Validated Invitro In-vivo Correlation. IJMMS 2010; 1: 4211-4214
19. Umeruqia T, Nisar UR. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets. Pak. J. Pharm. Sci. 2008; 211: 131-138
20. Clifford E B, Sang BP, Steven AW. In Vitro-In Vivo Correlations of Human-Nicotine Metabolism. Biochem. Pharmacol. 1995; 50: 565-570
21. Nattee S, Natalie DE. The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets. Eur. J. Pharm. Biopharm. 2002; 53: 301-309
22. Vinod PS. IV-IVC for topically applied preparations-a critical evaluation. Eur. J. Pharm. Biopharm. 2005; 60: 309-314
23. Jaleh V, Taghi G, Ahmad R. Biopharmaceutical characterization of oral theophylline and aminophylline tablets Quantitative correlation between dissolution and bioavailability studies. Eur. J. Pharm. Biopharm. 2000; 50: 301-306
24. Vibeke HS, Betty LP, Henning GK. In vivo - in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with bio relevant dissolution media. Eur. J. Pharm. Sci. 2005; 24: 305-313
25. Jennifer BD, Christos R. In vitro - in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11 Suppl. 2; 2000: S 73-S 80
26. John SG, Keith EA, James AR. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system II. Improved in vitro-in vivo correlation using a two-phase dissolution test. J. Control. Rel. 1997; 489-517
27. Lake OA, Olling M, Barends DM. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur. J. Pharm. Biopharm. 1999; 48: 13-19
28. Ekarat J, Vincenzo DM, Emanuela R. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Eur. J. Pharm. Sci. 2009; 37: 434-441
29. Hsiu OH, Cheng HL, Hua ML. The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation. J. Control. Rel. 1997; 49: 149-156
30. Lisbet B, Lars H, Henning GK. A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans. Eur. J. Pharm. Sci.1999; 819-827
31. Nilufer Y, Aysegul K, Yalcin O. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2003; 56: 453-459
32. Annke F, Helga M, Ehrenfried W. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxy methylpenicillin potassium, glimepiride and levofloxacin. Eur. J. Pharm. Biopharm. 1998; 46: 305-311
33. Raguia AS, Iman SA, Rehab N. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur. J. Pharm. Biopharm. 2009;73: 162-171
34. Iman SA, Mona HA. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin. Eur. J. Pharm. Sci 2007; 32: 58-68
35. Jelena P, Svetlana I, Zorica D. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. Eur. J. Pharm. Sci 2007; 30: 264-272
36. Sabah S, Stephanie B, Eric B. A level 'A' in vitro/in vivo correlation in fasted and fed states using different methods: Applied to solid immediate release oral dosage form. Eur. J. Pharm. Sci 2006; 27: 72-79
37. Nabais T, Brouillet F, Kyriacos S. High-amylose carboxy methyl starch matrices for oral sustained drug-release In vitro and in vivo evaluation. J. Control. Rel. 2007; 65: 371-378
38. Annke F, Helga M, Ehrenfried W. Biopharmaceutical characterization of oral controlled/modifiedrelease drug products. In vitro/in vivo correlation of roxatidine. Eur. J. Pharm. Biopharm.1998; 46: 313-319
39. Nadia MV, Regina LS, Ana PP. Multiple level C in vitro/in vivo correlation of dissolution profiles of two l-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Eur. J. Pharm. Sci. 2004; 21: 655-660
40. Parviz M, Jack R, Winston AV. In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine Sulfate. J. Pharm. Biomed. Anal. 1997; 15: 439-445
41. Lian DH, Yang L, Xing T. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur. J. Pharm. Biopharm. 2006; 64: 185-192
42. Mukesh CG, Maulik KP. Refinement of Lower Acceptance Value of the Similarity Factor f2 in Comparison of Dissolution Profiles. Dissolution Technologies 2002; 47: 1-5.
43. John GW. Application of the Wagner-Nelson absorption method to the two-compartment open model. J Pharmacokin and Pharmacodyn. 2003; 2 (6): 469-486
44. Gangadhar S, Dakshina M, Chilukuri. IVIVC: An Important Tool in the Development of Drug Delivery Systems. Drug delivery technology. 2003; Vol. 3
45. Guidance for Industry. Extended Release Oral Dosage Forms. Development, Evaluation, and Application of In Vitro/In Vivo Correlations, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). September 1997
46. Guidance for Industry. Dissolution Testing of Immediate, Release Solid Oral Dosage Forms, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). August 1997.